Kyntra Bio, Inc. (KYNB)

6.99 +0.05 (+0.72%) USD  |  NASDAQ  |  May 22, 16:00
6.98 -0.01 (-0.14%) After-Hours: 20:00
More

Kyntra Bio EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for KYNB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Anixa Biosciences, Inc. Upgrade
GT Biopharma, Inc. Upgrade
Perspective Therapeutics, Inc. Upgrade
XOMA Royalty Corp. Upgrade
Gossamer Bio, Inc. Upgrade